We recognize the variability of ARDS symptoms and etiology of ARDS, which stresses the importance of validating the therapeutic efficacy of IL-27 ASC in additional in vivo models to enhance clinical relevance. The gene discussed is IL27; the disease is acute respiratory distress syndrome.